We are carrying out a clinical trial of an investigational medicine being developed for the treatment of patients with a rare inherited liver disease known as ZZ Type Alpha-1 Antitrypsin Deficiency (AATD) Liver Disease.
You may be suitable to take part if you are healthy non-smoker aged 18 to 65 (inclusive), and you do not have any past or ongoing medical conditions that may interfere with your participation in this study.
This study will be carried out at our clinical trials unit at Croydon University Hospital in South London. Youíll first need to attend a screening appointment at our unit to check that you are suitable to take part. This study is made up of two parts, a Single Ascending Dose (SAD) part and a Multiple Ascending Dose (MAD) part. Volunteers may only take part in one part of the study. If you are included in the study you will need to stay at our unit for one / two in-patient stay/s of 2 nights and attend 9 / 15 x out-patient visits including a final follow up. Please see the study dates below.
Admission: Monday, 20 July
Dismissal: Thursday, 23 July
Visit 1: Tuesday, 28 July
Visit 2: Tuesday, 4 August
Visit 3: Tuesday, 11 August
Visit 4: Tuesday, 18 August
Visit 5: Tuesday, 25 August
Visit 6: Tuesday, 1 September
Visit 7: Tuesday, 15 September
Final follow-up visit: Tuesday, 29 September
In recognition of the time involved in taking part in this study, you will receive £1,380 on completion of the study provided you comply fully with all the study requirements. This amount is based on the anticipated study plan and will be adjusted pro-rata (i.e. same amount of money paid per unit of time), should we invite you to attend extra visits.
- Speak to our Volunteer Recruitment team
If you are interested in finding out more Click here to register
Email firstname.lastname@example.org for details
Or call us weekdays between 09h00 and 17h00 on +44 (0) 208 664 5200 (choose option 1) to speak to a member of our Volunteer Recruitment team.
If you donít meet the study criteria but have a friend or family member who may be suitable for this trial, you will compensated £90 for your referral if they go on to complete the study, or this payment can be donated to a charity of your choice.
With their consent please send your full name and your friendís or family member's name and contact telephone number to email@example.com
Ref: AL3_MAY 2015 (email_website_advert text)
The contents of this email have been approved by an ethics committee. Any response to this advertisement will be recorded. Your response will not place you under any obligation to participate in this trial.
You may be required to remain resident in the unit until resolution of any safety issues, after which you will be discharged from the unit.